Amgen Inc. Canadian Depositary Receipt (AMGN)
TSX
Closed
Aug 25, 2026
Day's Range
32.7252 wk Range
23.95Overview - AMGN - Amgen Inc. Canadian Depositary Receipt
Key Statistics
Valuation
Enterprise Value
371.79B
P/E (Trailing)
‪26.86‬
PEG Ratio
‪0.41‬
Price / Sales (TTM)
‪8.87‬
Price / Book
‪27.50‬
EV / EBITDA
‪22.00‬
Profitability
Gross Margin
‪72.04%‬
Profit Margin
‪67.24%‬
Operating Margin
‪31.92%‬
Return on Assets
‪8.51%‬
Return on Equity
‪89.06%‬
Ownership
Shares Outstanding
541.00M
Price stats
50-Day Avg
‪28.21‬
200-Day Avg
‪26.70‬
Dividends
Frequency
Quarterly
Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - AMGN - Amgen Inc. Canadian Depositary Receipt
Peers - AMGN - Amgen Inc. Canadian Depositary Receipt
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on TSX.
- AMGNTSXAmgen Inc. Canadian Depositary Receipt322.63BMarket Cap+22.78%52-week change26.10P/E (Trailing)‪67.24%‬Profit Margin
- LLYTSXEli Lilly CDR1.52TMarket Cap+39.07%52-week change39.42P/E (Trailing)‪83.04%‬Profit Margin
- ABBVTSXAbbVie Inc. CDR646.28BMarket Cap+20.22%52-week change71.23P/E (Trailing)‪70.23%‬Profit Margin
- JNJTSXJohnson & Johnson567.28BMarket Cap+35.04%52-week change27.92P/E (Trailing)‪21.83%‬Profit Margin
- MRKTSXMerck & Co., Inc.537.08BMarket Cap+44.46%52-week change124.50P/E (Trailing)‪74.80%‬Profit Margin
- ROGTSXRoche Holding AG American Depositary Receipt532.20BMarket Cap+21.55%52-week change22.33P/E (Trailing)‪73.72%‬Profit Margin
- PFETSXPfizer Inc. Canadian Depositary Receipt221.21BMarket Cap+10.38%52-week change35.33P/E (Trailing)‪74.32%‬Profit Margin
Profile Summary - AMGN - Amgen Inc. Canadian Depositary Receipt
About
Amgen Inc. Canadian Depositary Receipt (CDR) is a financial instrument that provides Canadian investors with exposure to Amgen Inc., a leading biotechnology company focused on developing innovative human therapeutics. This CAD-hedged CDR represents fractional ownership of Amgen Inc. common stock through a dynamic CDR…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
